#1 Clinical Trials Search in Europe

Magnesium Oxide, Light

This article discusses a clinical trial comparing the effectiveness and tolerability of two bowel cleansing agents, Plenvu® and Picoprep®, used before colonoscopy procedures. The study aims to determine if Plenvu®, a newer low-volume preparation, is as effective as the well-established Picoprep® while potentially offering better compliance and tolerability for patients undergoing colonoscopy to exclude colorectal cancer.

Table of Contents

What is Magnesium Oxide, Light?

Magnesium Oxide, Light is a chemical compound that plays a crucial role in certain medical preparations. In the context of this article, it is one of the active ingredients in a bowel cleansing agent called Picoprep[1]. Magnesium Oxide, Light is classified as a Specified Substance Group 1, which means it has specific properties that make it suitable for pharmaceutical use.

Medical Use in Bowel Cleansing

Magnesium Oxide, Light is primarily used in bowel cleansing preparations. These preparations are essential for patients who are about to undergo a colonoscopy, which is an examination of the large intestine (colon) using a flexible camera[1]. The main purpose of using Magnesium Oxide, Light in these preparations is to help clear the bowel, allowing for better visualization of the colon during the procedure.

Picoprep: A Bowel Cleansing Agent

Picoprep is a specific bowel cleansing agent that contains Magnesium Oxide, Light as one of its active ingredients. The full list of active substances in Picoprep includes:

  • Sodium Picosulfate: A stimulant laxative that increases bowel movement
  • Magnesium Oxide, Light: Helps draw water into the bowel, softening stool
  • Citric Acid: Aids in the overall effectiveness of the preparation

Picoprep comes in the form of a powder that is mixed with water to create an oral solution. This solution is then consumed by the patient to cleanse their bowel before a colonoscopy[1].

Clinical Trial: Comparing Bowel Cleansing Agents

A clinical trial is being conducted to compare the effectiveness and tolerability of two bowel cleansing agents: Plenvu and Picoprep. The main objectives of this trial are:

  1. To compare the efficacy (how well it works) of Plenvu and Picoprep in cleansing the bowel before a colonoscopy[1].
  2. To compare how well patients tolerate these two preparations[1].

This trial aims to determine if Plenvu, which is a newer preparation, is as effective as Picoprep while potentially being easier for patients to take.

Patient Considerations and Precautions

While Magnesium Oxide, Light is generally safe when used as directed in bowel cleansing preparations, there are some important considerations for patients:

  • The maximum daily dose of Picoprep is typically 1 unit, with a maximum total dose of 2 units over a 2-day period[1].
  • Picoprep is taken orally (by mouth)[1].
  • Certain patients should not use Picoprep or similar preparations containing Magnesium Oxide, Light. These include:
    • Patients with phenylketonuria (a genetic disorder that affects how the body processes certain proteins)[1]
    • Patients with glucose-6-phosphate dehydrogenase deficiency (a genetic disorder that affects red blood cells)[1]
    • Patients with severe heart failure or severe kidney problems[1]
    • Pregnant or breastfeeding women[1]
    • Patients with narrowing of the colon (colonic stenosis)[1]

It’s crucial for patients to discuss their medical history and any concerns with their healthcare provider before using any bowel cleansing preparation containing Magnesium Oxide, Light.

Aspect Details
Study Type Randomized controlled trial
Medications Compared Plenvu® and Picoprep®
Primary Objective Compare efficacy and tolerability of bowel cleansing agents
Patient Group Patients undergoing colonoscopy to exclude colorectal cancer
Main Inclusion Criteria Ambulant colonoscopy
Key Exclusion Criteria Phenylketonuria, G6PD deficiency, severe heart/renal failure, pregnancy
Primary Endpoint Efficacy of Plenvu® is not inferior to Picoprep®
Secondary Endpoint Tolerability of Plenvu® is not inferior to Picoprep®

FAQ

  • What is the purpose of this clinical trial? The trial aims to compare the efficacy and tolerability of Plenvu® and Picoprep® as bowel cleansing agents before colonoscopy, to see if Plenvu® is as effective as Picoprep® with potentially better compliance and tolerability.
  • Who can participate in this trial? Patients undergoing ambulant colonoscopy to exclude colorectal cancer can participate. However, there are several exclusion criteria, such as having phenylketonuria, glucose-6-phosphate-dehydrogenase deficiency, or severe heart or renal failure.
  • What are Plenvu® and Picoprep®? Plenvu® is a relatively new, low-volume Polyethylene Glycol-electrolytes lavage solution. Picoprep® is a well-established bowel preparation containing sodium picosulfate, magnesium oxide, and citric acid.
  • How does the cleansing process affect the colonoscopy? The cleansing process is crucial as it affects the visualization of the bowel mucosa, which directly impacts the quality of the colonoscopy examination.
  • What are the main outcomes the researchers are looking for? The primary outcome is to determine if Plenvu®'s efficacy is not inferior to Picoprep®. The secondary outcome is to compare the tolerability of both agents.

Ongoing Clinical Trials on Magnesium Oxide, Light

  • A study comparing the effectiveness of a simeticone drug combination and a sodium picosulfate drug combination for bowel preparation in patients undergoing colorectal cancer screening.

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Bowel Cleansing Agents Plenvu and Picoprep for Patients Undergoing Colonoscopy to Exclude Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Colonoscopy: A medical procedure where a long, flexible tube with a camera is inserted into the rectum to examine the entire colon for abnormalities or disease.
  • Bowel cleansing agent: A substance used to clear the bowels of fecal matter before a colonoscopy, ensuring clear visibility during the procedure.
  • Efficacy: The ability of a treatment or drug to produce the desired result.
  • Tolerability: The degree to which side effects of a drug or treatment can be endured by a patient.
  • Polyethylene Glycol (PEG): A compound used in some bowel preparation solutions to help cleanse the colon.
  • Phenylketonuria: A rare genetic disorder that causes an amino acid called phenylalanine to build up in the body.
  • Glucose-6-phosphate-dehydrogenase deficiency: A genetic disorder that affects red blood cells and can cause hemolytic anemia.
  • eGFR: Estimated Glomerular Filtration Rate, a test used to check how well the kidneys are working.
  • Colonic stenosis: A narrowing of the colon that can obstruct the passage of stool.
  • Mucosa: The inner lining of the intestines that secretes mucus and absorbs nutrients.

References

  1. http://clinicaltrials.eu/trial/study-comparing-bowel-cleansing-agents-plenvu-and-picoprep-for-patients-undergoing-colonoscopy-to-exclude-colorectal-cancer/